ozempic lawsuit Updates
Study Links Ozempic to Medical Imaging Interference, Complicating Diagnoses
New research indicates that Ozempic and similar GLP-1 drugs can interfere with PET scan results, causing contrast solutions to display abnormal patterns. This interference raises the risk of misdiagnosis—including false cancer positives or incorrect cancer staging—potentially leading to unnecessary medical procedures. This newly identified issue adds to the spectrum of severe complications reported by patients, such as gastroparesis, pancreatitis, and vision loss, which form the basis of ongoing litigation against the manufacturer, Novo Nordisk.
Widespread Use of GLP-1 Drugs Documented in National Survey, Amid Growing Litigation
A recent national survey by the RAND Corporation indicates approximately 12% of Americans have used a GLP-1 drug like Ozempic, with usage rising to 20% among women aged 50 to 64. The survey also found that at least half of users report side effects such as nausea. While many experience common side effects, thousands of others have suffered more severe complications, which have subsequently formed the basis of extensive litigation against the manufacturer, Novo Nordisk
Ozempic Litigation Surpasses 2,800 Cases Amid Novo Nordisk Corporate Challenges
As of October 2025, 2,809 active lawsuits are pending in the federal Ozempic multidistrict litigation in Pennsylvania. The litigation continues to grow as more patients alleging severe side effects from GLP-1 drugs file claims. This increase coincides with notable corporate challenges for manufacturer Novo Nordisk, including the departure of seven board members and pressure from market competition. The combination of mounting litigation and financial pressures presents significant difficulties for the company.
Study Links Ozempic to Higher Incidence of Acute Kidney Injury
A recent analysis of FDA adverse event data found that Ozempic (semaglutide) is associated with a higher incidence of acute kidney injury (AKI). Among 92,807 adverse event reports for semaglutide drugs, approximately 440 cases of AKI were identified. The study noted this incidence was significantly higher compared to the drug tirzepatide. These kidney injuries are cited in lawsuits filed against manufacturer Novo Nordisk by patients who experienced harm after taking Ozempic.
About the Ozempic Lawsuit
The Ozempic lawsuit has recently gained significant attention as concerns have been raised about Ozempic long term side effects, including gastroparesis, thyroid C-cell tumors, and other serious illnesses.
The core issue of the Ozempic class action lawsuit is the potential serious health risks associated with the use of Ozempic, a medication commonly prescribed to manage type 2 diabetes by controlling blood sugar levels. These issues have led to numerous reports and studies focusing on the potential dangers of the active ingredient in Ozempic, semaglutide.
People afflicted with Ozempic's long-term side effects include individuals who have been prescribed the medication for diabetes management and subsequently experienced serious health issues. Individuals who used Ozempic for weight loss were unaware of the potential risks associated with the medication.
Victims who used Ozempic for weight loss are facing significant health challenges, permanent disabilities, and, in some cases, life-threatening conditions. Many people are unaware of the risks and continue using the medication, only to experience severe health issues. Legal avenues are now available for those affected, allowing them to submit an application and seek potential compensation for the harm caused by Ozempic.
If you or a loved one have suffered serious health issues after using Ozempic, it is crucial to understand your rights and the potential for participating in the Ozempic lawsuit to seek justice and compensation.
Who Qualifies for the Ozempic Lawsuit?
There are specific criteria you must meet to potentially qualify for the Ozempic lawsuit. These requirements include.
Medication Use:
You must have been prescribed and used Ozempic between 2018 and to present.
Health Conditions: You must have been diagnosed with one of the following Ozempic side effects:
- Persistent cyclical vomiting for +4 weeks (diagnosis must be while taking the product OR within 60 days of stopping and must have experienced vomiting 1 month or more)
- Gastric Injury (diagnosis must be while taking product OR within 60 days of stopping)
- A gastric injury is any injury related to the gastrointestinal tract
- Ileus
- Gastroparesis/ stomach paralysis
- Pulmonary Aspiration (associated with anesthesia/surgery)
- Deep Vein Thrombosis (DVT)
- Esophageal Injury
If you do not have a valid cancer diagnosis from your doctor but have experienced Ozempic side effects, you may still be included in the Ozempic lawsuit.
If you meet these requirements, you may be entitled to compensation and should seek legal advice to determine your eligibility.
Which Companies Are Involved in the Ozempic Lawsuit?
Several manufacturers and their respective products are commonly implicated in the Ozempic lawsuit, however, the primary company involved is Novo Nordisk. Novo Nordisk is facing numerous lawsuits alleging that the science behind Ozempic was wrong and that it has led to serious health conditions, including gastroparesis, ileus, and other significant health issues.
These Ozempic lawsuits claim that Novo Nordisk failed to adequately warn users about the potential risks associated with the drug's active ingredient, semaglutide. As more evidence emerges linking to Ozempic's long-term side effects, the number of cases against the company is expected to increase. If you or a loved one have experienced adverse health effects after using Ozempic, you may qualify to join the ongoing litigation.
How Much Compensation Should You Expect In Your Ozempic Lawsuit?
Determining a typical settlement amount in the Ozempic lawsuit is complex due to the unique nature of each case. Factors such as the severity of the illness, the strength of the evidence, jury decisions, and the skill of the lawyers involved all influence the settlement amount.
As of now, the Ozempic lawsuits are in the early stages, and no global settlements or jury trials have been reported. However, based on other pharmaceutical litigation and the current scope of the Ozempic cases, potential settlement amounts can be anticipated based on the type and extent of harm suffered by plaintiffs.
Add Comment